COVID-19: Booster doses only mitigate disease severity, do not fully prevent infection
Though 90.8 million people above 60 years, 9.7 million health-care workers and nearly 17 million frontline workers have received the
Read More
Year: 2022
COVID-19: Are there clinical trial data to support a homologous vaccine booster?
This means those who have received Covishield as their first and second dose will receive Covishield as their third dose.
Read More
Conflicting signals from drug regulator, COVID-19 national task force
“Considering the emergency and unmet medical need in Covid-19, the SEC on December 27 recommended for grant of permission to
Read More
COVID-19: Even if mild, Omicron variant can overwhelming health-care settings
Huge percentage of the population in India got infected when the Delta variant raged through the country. Studies from other
Read More
Does Covaxin have WHO’s approval for use in children?
While clearly stating that teenagers aged 15 years or more (all those whose birth year is 2007 or before) will
Read More
COVID-19: India widens the vaccine safety net by immunising teenagers above 15 years
With all adults aged 18 years and above already being covered, the inclusion of teenagers has reduced the eligibility age
Read More
COVID-19: The basis on which India approved precaution dose remains unclear
He said the primary focus of the government was on giving a second dose of the vaccine to make people
Read More
COVID-19: India should prepare for the worst with Omicron
The World Health Organization said the number of COVID-19 cases recorded globally shot up by 11% last week (December 20-26)
Read More